Genasense (oblimersen)
- Region
- 🇪🇺 EU
- Active substance
- oblimersen
- Company
- Genta Development Ltd. c/o Ross Craig
- Status
- Refused
- Therapeutic area
- Melanoma
- CHMP opinion
- Thu 19 Jul 2007
- Application
- EMEA/H/C/000711
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Follow Genasense
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.